Aspen Aerogels Inc. (ASPN)
Aspen Aerogels Statistics
Share Statistics
Aspen Aerogels has 82.1M shares outstanding. The number of shares has increased by 7.02% in one year.
Shares Outstanding | 82.1M |
Shares Change (YoY) | 7.02% |
Shares Change (QoQ) | 6.44% |
Owned by Institutions (%) | 95.65% |
Shares Floating | 80.69M |
Failed to Deliver (FTD) Shares | 337 |
FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 10.51M, so 12.82% of the outstanding shares have been sold short.
Short Interest | 10.51M |
Short % of Shares Out | 12.82% |
Short % of Float | 13.01% |
Short Ratio (days to cover) | 6.58 |
Valuation Ratios
The PE ratio is 68.87 and the forward PE ratio is 22.27. Aspen Aerogels's PEG ratio is -0.55.
PE Ratio | 68.87 |
Forward PE | 22.27 |
PS Ratio | 2.03 |
Forward PS | 0.5 |
PB Ratio | 1.5 |
P/FCF Ratio | -22.62 |
PEG Ratio | -0.55 |
Enterprise Valuation
Aspen Aerogels Inc. has an Enterprise Value (EV) of 1.09B.
EV / Earnings | 81.84 |
EV / Sales | 2.42 |
EV / EBITDA | 22.08 |
EV / EBIT | 20.07 |
EV / FCF | -26.88 |
Financial Position
The company has a current ratio of 3.72, with a Debt / Equity ratio of 0.17.
Current Ratio | 3.72 |
Quick Ratio | 3.29 |
Debt / Equity | 0.17 |
Total Debt / Capitalization | 14.28 |
Cash Flow / Debt | 0.44 |
Interest Coverage | 4.56 |
Financial Efficiency
Return on equity (ROE) is 0.02% and return on capital (ROIC) is 6.74%.
Return on Equity (ROE) | 0.02% |
Return on Assets (ROA) | 0.01% |
Return on Capital (ROIC) | 6.74% |
Revenue Per Employee | $817,146.21 |
Profits Per Employee | $24,142.6 |
Employee Count | 554 |
Asset Turnover | 0.51 |
Inventory Turnover | 5.67 |
Taxes
Income Tax | 1.71M |
Effective Tax Rate | 0.11 |
Stock Price Statistics
The stock price has increased by -62.56% in the last 52 weeks. The beta is 2.28, so Aspen Aerogels's price volatility has been higher than the market average.
Beta | 2.28 |
52-Week Price Change | -62.56% |
50-Day Moving Average | 9.12 |
200-Day Moving Average | 18.1 |
Relative Strength Index (RSI) | 31.22 |
Average Volume (20 Days) | 1.93M |
Income Statement
In the last 12 months, Aspen Aerogels had revenue of 452.7M and earned 13.38M in profits. Earnings per share was 0.17.
Revenue | 452.7M |
Gross Profit | 182.9M |
Operating Income | 54.53M |
Net Income | 13.38M |
EBITDA | 49.57M |
EBIT | 54.53M |
Earnings Per Share (EPS) | 0.17 |
Balance Sheet
The company has 220.88M in cash and 102.42M in debt, giving a net cash position of 118.46M.
Cash & Cash Equivalents | 220.88M |
Total Debt | 102.42M |
Net Cash | 118.46M |
Retained Earnings | -660.23M |
Total Assets | 895.14M |
Working Capital | 299.34M |
Cash Flow
In the last 12 months, operating cash flow was 45.55M and capital expenditures -86.26M, giving a free cash flow of -40.71M.
Operating Cash Flow | 45.55M |
Capital Expenditures | -86.26M |
Free Cash Flow | -40.71M |
FCF Per Share | -0.53 |
Margins
Gross margin is 40.4%, with operating and profit margins of 12.05% and 2.95%.
Gross Margin | 40.4% |
Operating Margin | 12.05% |
Pretax Margin | 3.33% |
Profit Margin | 2.95% |
EBITDA Margin | 10.95% |
EBIT Margin | 12.05% |
FCF Margin | -8.99% |
Dividends & Yields
ASPN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 2.58% |
FCF Yield | -7.52% |
Analyst Forecast
The average price target for ASPN is $18, which is 173.1% higher than the current price. The consensus rating is "Buy".
Price Target | $18 |
Price Target Difference | 173.1% |
Analyst Consensus | Buy |
Analyst Count | 10 |
Scores
Altman Z-Score | 2.59 |
Piotroski F-Score | 8 |